Description
Tesamorelin 6mg + Ipamorelin 3mg + CJC No DAC 3mg Blend (12mg Total) — Lyophilized Research Peptide
Tesamorelin 6mg + Ipamorelin 3mg + CJC No DAC 3mg is a blended, lyophilized peptide vial designed for research exploring
GH/IGF-1 axis signaling, pituitary secretory dynamics, and endocrine-related biomarker readouts. Each vial contains
12mg total (6mg Tesamorelin + 3mg Ipamorelin + 3mg CJC No DAC) with ≥99% purity and a lot-specific COA available.
This Tesamorelin + Ipamorelin + CJC No DAC blend is commonly referenced in laboratory settings as a multi-pathway
growth-hormone signaling research combination. Investigators use these peptides as tools to study endocrine feedback loops,
pituitary signaling pathways, GH pulsatility, and downstream metabolic markers under controlled experimental conditions.
What It Is
- Class: Synthetic peptide blend: GHRH analogs + growth-hormone secretagogue
- Research purpose: Used as an experimental tool for studying GH pulsatility, GH/IGF-1 axis activity, pituitary signaling, and endocrine feedback regulation.
- Common lab readouts: Hormone signaling markers, IGF-1–related measurements, gene/protein expression panels, and endocrine/metabolic biomarker tracking.
Proposed Mechanisms & Pathways (Preclinical)
GH Release Signaling
- Tesamorelin: Studied for activation of GHRH-receptor pathways in models assessing pituitary signaling and GH-related readouts.
- CJC No DAC: Investigated as a short-acting GHRH analog in research models focused on GH pulse dynamics and receptor-mediated signaling.
- Ipamorelin: Investigated for activity in growth-hormone secretagogue signaling, often referenced alongside ghrelin/GHSR-related research.
Downstream Biomarkers & System Readouts
- GH-linked pathways are frequently tracked through IGF-1–related measurements and downstream signaling markers.
- Research designs may include metabolic panels, body-composition proxy markers, and endocrine biomarker tracking depending on the model and endpoints.
- Blended preparations are used to explore complementary GHRH-pathway and secretagogue-pathway signaling in controlled experimental systems.
Selected Research Highlights
- GH/IGF-1 Axis: Used to probe pituitary output patterns and downstream signaling cascades associated with GH biology.
- Secretory Dynamics: Included in research examining GH pulse patterns, receptor-mediated signaling, and hormone feedback regulation.
- Endocrine Biomarkers: Utilized in controlled models measuring endocrine-linked metabolic readouts alongside pathway markers.
Chemical & Handling Information
- Type: Lyophilized peptide blend: Tesamorelin + Ipamorelin + CJC No DAC
- Appearance: White to off-white lyophilized powder; hygroscopic; handle promptly.
- General handling: Protect from moisture, excessive heat, and light during routine laboratory handling.
Storage & Stability
- Store lyophilized vials in a cool, dry place, protected from light and moisture.
- Refrigeration or freezing of the lyophilized material is recommended for extended stability, according to laboratory SOPs.
- After reconstitution, store at 2–8 °C for short-term use.
- For longer-term storage, aliquot and freeze at −20 °C or below; avoid repeated freeze–thaw cycles.
FAQ
What is the vial content and total amount?
Each vial contains 12mg total: Tesamorelin 6mg + Ipamorelin 3mg + CJC No DAC 3mg in lyophilized powder form.
Is a COA available?
Yes—purity is listed as ≥99% (HPLC) with a COA available per lot. You can link users to your Lab Tests page.
How should the material be stored?
Store dry vials in a cool, dry place. After reconstitution, refrigerate 2–8 °C short-term or freeze −20 °C for long-term storage; avoid repeated freeze–thaw cycles.
Research use only. Not for human or veterinary use. For Tesamorelin + Ipamorelin + CJC No DAC blended research vials, visit
MyPurePeptide.com.
Reviews
There are no reviews yet.